BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7319478)

  • 1. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography.
    Southan C; Thompson E; Lane DA
    Thromb Res; 1986 Jul; 43(2):195-204. PubMed ID: 3738859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of human fibrinopeptides by high-performance liquid chromatography.
    Ebert RF; Bell WR
    Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of bovine fibrinopeptides by high performance liquid chromatography.
    Martinelli RA; Scheraga HA
    Anal Biochem; 1979 Jul; 96(1):246-9. PubMed ID: 495988
    [No Abstract]   [Full Text] [Related]  

  • 6. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and assay of phosphoserine and tyrosine-O-sulphate in fibrinopeptides by reversed-phase high-performance liquid chromatography.
    Lucas J; Henschen A
    J Chromatogr; 1986 Nov; 369(2):357-64. PubMed ID: 3100570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new truncated form and deamidation products of fibrinopeptide B released by thrombin from human fibrinogen.
    Cardinali B; Damonte G; Melone L; Salis A; Tosetti F; Rocco M; Profumo A
    Thromb Haemost; 2006 Sep; 96(3):302-8. PubMed ID: 16953271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of human fibrinopeptides by capillary zone electrophoresis.
    Profumo A; Cardinali B; Cuniberti C; Rocco M
    Electrophoresis; 2005 Feb; 26(3):600-9. PubMed ID: 15690433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).
    Dyr JE; Hessel B; Suttnar J; Kornalík F; Blombäck B
    Toxicon; 1989; 27(3):359-73. PubMed ID: 2728027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
    Nossel HL
    N Engl J Med; 1976 Aug; 295(8):428-32. PubMed ID: 59314
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
    Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
    Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 18. The action of a fibrin-promoting enzyme from the venom of Agkistrodon contortrix contortrix on rat fibrinogen and plasma.
    Dyr JE; Suttnar J; Simák J; Fortová H; Kornalík F
    Toxicon; 1990; 28(11):1364-7. PubMed ID: 2087698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
    Budzynski AZ; Marder VJ
    Thromb Diath Haemorrh; 1975 Dec; 34(3):709-17. PubMed ID: 1209541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.